Health Insurance News Novo Ready To Seek German Insurance Coverage Of Wegovy For Heart Use

Novo’s Wegovy Beats Lilly’s Zepbound for Heart Health, Study Finds. What It Means for Stocks.

Novo Nordisk’s Wegovy cut the risk of heart attacks, stroke and death by more than Eli Lilly’s weight-loss drug Zepbound, a new study found. Compared with tirzepatide—the active ingredient in Zepbound ... Read More

GoodRx, Novo Nordisk partner to offer Ozempic, Wegovy

Prescription savings platform GoodRx is collaborating with pharma giant Novo Nordisk to make Ozempic and Wegovy pens available to eligible self-paying patients using GoodRx for $499 per month at ... Read More

CVS PBM Caremark exploring $200 copay for Novo Nordisk's Wegovy - report

Caremark, the pharmacy benefit manager owned by CVS Health (NYSE:CVS), is reportedly trying to get Novo Nordisk (NVO) to agree to cover a month's supply of its blockbuster GLP-1 weight loss treatment ... Read More

Novo Nordisk's Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study

While this was not a randomized controlled trial, Novo said the findings provide evidence that the heart-protective benefits of Wegovy and its main ingredient semaglutide may not be the same for all ... Read More

Costco to sell Ozempic and Wegovy at a large discount for people without insurance

At $499 a month, the deal will help expand access to Novo Nordisk's weight loss drugs, but doctors say the hugely popular medications will still be out of reach for many who need them. Read More

Costco to sell Ozempic, Wegovy for $499 a month

Pharmaceutical company Novo Nordisk announced Friday that Costco will begin selling monthly supplies of Ozempic and Wegovy for $499 to uninsured members. The discounted price comes as more ... Read More

As insurers struggle with weight-loss drug costs, some seek to wean patients off

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April. Her request for coverage had been denied ... Read More

Novo Nordisk Says Wegovy Cuts Heart Risk by 57% Compared With Eli Lilly’s Obesity Drug

Novo Nordisk said its blockbuster Wegovy weight-loss drug cuts the risk of heart attack, stroke or death by 57% compared with Eli Lilly’s Mounjaro and Zepbound. The Danish pharmaceutical giant said ... Read More

Costco to sell Ozempic and Wegovy at a large discount for people without insurance

Ozempic and Wegovy are coming to a Costco near you. Novo Nordisk, the company that makes Ozempic and Wegovy, announced Friday it will be selling the prescription injectable pens at the warehouse chain ... Read More